推荐应用
Butyrophilin 3A1 (also called BTN3A1) is a 57 kDa type I transmembrane glycoprotein member of the Ig superfamily. It is expressed on a wide variety of immune cells. Similar to BTN3A2 and BTN3A3, BTN3A1 (484 amino acids) is composed of an extracellular N-terminal IgV and a membrane-proximal IgC domain followed by a transmembrane domain and a cytoplasmic tail. These Ig domains are also found in B7 family co-stimulatory molecules, suggesting structural and functional similarities between the two protein families . The intracellular portion of BTN3A1 contains a B30.2 domain. Although the B30.2 domain of BTN1A1 binds to xanthine oxidoreductase (XOR) and is conserved among BTN1A1 orthologs, this interaction with XOR is not shared by BTN3A1. The B30.2 domain of butyrophilins also functions as a sensor for detecting changes in intracellular phopho-antigen (pAg) concentrations produced during tumorigenesis and microbial infections. The specific binding of pAg by the B30.2 domain of BTN3A1 induces a conformational change in its ECD, leading to the activation of V gamma 9Vδ2 T cells. Thus, BTN3A1 acts as a critical protein for the activation of V gamma 9Vδ2 T cells following detection of distressed cells. The anti-tumor responses of V gamma 9Vδ2 T cells may be enhanced with agonistic anti-BTNA3 antibodies . No BTN3A1 homolog has yet been identified in rodents.
高纯度、高活性、低内毒素、高批间一致性
产品数据


-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白
182
2026-08-31
【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白
193
2026-08-31
【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白
218
2026-08-31
【文献解读】Science 重磅成果:西湖大学团队攻克共价蛋白药物核心瓶颈,建立通用高通量速效蛋白筛选平台
385
2026-06-25
【技术讲解】信号通路系列 | Wnt/β-catenin信号通路:细胞的“信号转换器”与“命运规划师”
739
2026-04-29
【文献解读】EGFR信号通路的耐药新视角:当EGFR-TKI遇上免疫压力,肿瘤如何“金蝉脱壳”?
541
2026-04-29
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
1137
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
847
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
715
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
791
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
1043
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
963
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
1560
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14719
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11320
2026-09-21





